We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LLL
601
DELISTED
L3 Technologies, Inc.
LLL
| $1.48M | 0.01% |
6,942
-42
| -0.6% | -$8.74K |
|
602
Entergy
ETR
$53.1B
| $1.46M | 0.01% |
35,956
-5,288
| -13% | -$219K |
|
603
Middleby
MIDD
$6.15B
| $1.46M | 0.01% |
11,264
| – | – |
|
604
Moody's
MCO
$84.2B
| $1.39M | 0.01% |
8,333
-118
| -1% | -$20.8K |
|
605
Brown & Brown
BRO
$23.6B
| $1.39M | 0.01% |
46,988
+8
| +0% | +$238 |
|
606
Texas Pacific Land
TPL
$27.4B
| $1.38M | 0.01% |
14,400
| – | – |
|
607
iShares Core MSCI EAFE ETF
IEFA
$188B
| $1.38M | 0.01% |
+21,500
| New | +$1.37M |
|
608
Royal Caribbean
RCL
$81.8B
| $1.38M | 0.01% |
10,603
-22,557
| -68% | -$2.64M |
|
609
Hubbell
HUBB
$26.3B
| $1.35M | 0.01% |
10,088
-288
| -3% | -$35.4K |
|
610
Weyerhaeuser
WY
$17.2B
| $1.34M | 0.01% |
41,415
+19,703
| +91% | +$684K |
|
611
Philips
PHG
$24.3B
| $1.32M | 0.01% |
37,474
-2,483
| -6% | -$84.9K |
|
612
L3Harris
LHX
$56.5B
| $1.32M | 0.01% |
7,816
-672
| -8% | -$107K |
|
613
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.29B
| $1.32M | 0.01% |
+15,031
| New | +$1.29M |
|
614
Lincoln Electric
LECO
$14.1B
| $1.3M | 0.01% |
13,926
+10,000
| +255% | +$925K |
|
615
Dover
DOV
$27.7B
| $1.26M | 0.01% |
14,237
+306
| +2% | +$25.3K |
|
616
iShares MSCI Japan ETF
EWJ
$21.7B
| $1.25M | 0.01% |
+20,783
| New | +$1.21M |
|
617
Sempra
SRE
$59.7B
| $1.24M | 0.01% |
21,802
-544
| -2% | -$31.5K |
|
618
Applied Industrial Technologies
AIT
$12.9B
| $1.24M | ﹤0.01% |
15,787
+14,355
| +1,002% | +$1.09M |
|
619
Universal Health Services
UHS
$9.64B
| $1.23M | ﹤0.01% |
9,604
+654
| +7% | +$80.3K |
|
620
NOV
NOV
$7.35B
| $1.23M | ﹤0.01% |
28,474
+527
| +2% | +$23.6K |
|
621
Voya Financial
VOYA
$8.98B
| $1.22M | ﹤0.01% |
24,616
+18,103
| +278% | +$895K |
|
|
ABMD
622
DELISTED
Abiomed Inc
ABMD
| $1.21M | ﹤0.01% |
2,684
-262
| -9% | -$103K |
|
623
Urban Outfitters
URBN
$6.22B
| $1.2M | ﹤0.01% |
+29,241
| New | +$1.31M |
|
|
ATHN
624
DELISTED
Athenahealth, Inc.
ATHN
| $1.2M | ﹤0.01% |
8,956
| – | – |
|
625
Ventas
VTR
$48.7B
| $1.19M | ﹤0.01% |
21,954
-9,874
| -31% | -$572K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.